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Background: Gamma  radiation  effects  on  the  erythrocyte  membrane  from  three  different
functional parts,  lipid  bilayer,  cytoskeleton  and  protein  components.  When  the  red  cell
membrane
 
is 
 
exposed 
 
to 
 
radiation, 
 
it 
 
loses 
 
its 
 
integrity 
 
and 
 
hemoglobin 
 
leaks 
 
out. 
 
In 
 
addi­
tion,
 
irradiation 
 
leads 
 
to 
 
lipid 
 
peroxidation 
 
and 
 
the 
 
products 
 
of 
 
this 
 
process, 
 
leading 
 
to
hemolysis.
 
The 
 
aim 
 
of 
 
the 
 
present 
 
study 
 
was 
 
to 
 
measure 
 
osmotic 
 
fragility 
 
(OF) 
 
of 
 
red b
 
lood
cells
 
and
 
malondialdehyde 
 
(MDA) 
 
levels 
 
as 
 
a 
 
marker 
 
of 
 
oxidative 
 
injury 
 
in 
 
breast 
 
cancer
patients
 
treated 
 
with 
 
radiation 
 
and 
 
chemotherapy. reast cancer 
ed blood  cell 
Materials
 
 and
 
 Methods: 
 
The 
 
OF 
 
test 
 
was 
 
performed 
 
using 
 
different 
 
concentrations 
 
of 
 
a 
 
salt 
solution. The 11 
  
 measurement 
 
of 
 
MDA 
 
was 
 
done 
 
with 
 
chemical 
 
methods. The sampling
 
 wa
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smotic 
 
fragility 
alondialdehyde 
taken
 
 during 
 
three 
 
stages 
 
of 
 
treatment: 
 
ﬁrst 
 
sample 
 
was 
 
taken befor
 
e starting
 
 c
 
hemotherapy, 
the
 
 second
 
 sample 
 
was 
 
taken 
 
before 
 
radiation 
 
therapy 
 
and 
 
the 
 
third 
 
sample wa
 
s taken
 
 after
 
 
radiotherapy. 
Results:
 
 No
 
 statistically 
 
signiﬁcant 
 
differences 
 
between 
 
levels 
 
of 
 
MDA 
 
in 
 
these 
 
three 
 
stages 
of
 
 treatment 
 
were 
 
observed. 
 
However, 
 
the 
 
comparison 
 
of 
 
mean 
 
levels 
 
of 
 
MDA 
 
showed 
 
an 
increase
 
 after 
 
radiotherapy. 
 
The 
 
OF 
 
rate 
 
did 
 
not 
 
show 
 
signiﬁcant 
 
difference 
 
(P >
 
 0.05)
 
 during
 
 
the
 
 stages
 
 of 
 
treatment. 
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Conclusion: In a standard treatment program of radiotherapy and chemotherapy lipid perox­
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1. Background 
Breast cancer is a major public health problem in the world,
with incidence ofmore than one million a year, and nearly half
of it occurs in North America and Europe.1 In 2012, 1.7 million
new cases of breast cancer were diagnosed worldwide, and
in the same year 52,2000 women died from it.2 The progno­
sis of this disease depends on the tumor characteristics and
quality of treatments. These treatments include systemic and
local approaches based on chemotherapy and then hormonal
interventions to prevent or delay metastasis.1 Approximately
5–10% of breast and ovarian cancers are hereditary and 30–50%
are autosomal dominant mutations. Deleterious gene muta­
tions in BRCA1 and BRCA2 are responsible for hereditary breast
3cancer.
Gamma rays used in radiotherapy have different biological
effects on the membrane of red blood cells. Free radicals that
are produced during body irradiation can cause membrane
changes including lipid peroxidation, phospholipid hydroly­
sis and disulﬁde bridged formation.4 Also, these changes in
the cell membrane may affect the cytoskeleton. The effect
of free radicals on the erythrocyte membrane and cytoskele­
ton can cause defects and hemolysis in the red blood cells
and hemoglobin leakage.5 For evaluation of osmotic fragility
of red blood cells and disease diagnosis related to hemoly­
sis osmotic fragility (OF), a test was performed.6 Patients with
breast cancer under adjuvant treatment suffer from a decrease
in hemoglobin concentration that in cancer patients has been
related to high levels of fatigue and depression with a decrease
in physical activity, quality of life and survival.7 Based on the
previous studies, the importance of this test is to conﬁrm that
the membrane property and morphology of red blood cells is
abnormal.6 
The free radicals from radiation have a high afﬁnity to the
lipid membrane, which may cause damage to the membrane.
These damaged lipid molecules are hardly back to the initial
state and cause a gap in the cell and disorder in exchanging
important intracellular minerals.8,9 To evaluate the oxidative
damage of erythrocyte, malondialdehyde (MDA) was used as
a marker for measuring lipid peroxidation levels.10 The aim
of this study was to evaluate the effect of radiotherapy and
chemotherapy on the fragility of red blood cells and plasma
MDA levels as a marker of oxidative damage. 
2. Materials and methods Please cite this article in press as: Khoshbin AR, et al. The effect of radiot
plasma levels of malondialdehyde in patients with breast cancer. Rep Prac
              
          
        
        
 
         
        
This descriptive-analytical study was performed in 2013 on 17 
patients with breast cancer recently diagnosed and who had 
followed surgery. 
Fasting venous blood was taken for OF and MDA mea­
surement. OF was evaluated by a method using different   
           
 
        
       
         
       
         
       
     
    
           
        
        
        
        
 
  
       
       
        
         
        
 
 
        
          
          
         
     
           
        
     
 
           
       
          
         
        
         
t signiﬁcantly increase. 
ancer Centre. Published by Elsevier Urban & Partner Sp. z o.o. All 
rights reserved. 
concentrations of salt solution and MDA was assayed with 
the chemical method developed by Satoh.11 The sampling was 
taken during three stages of treatment: ﬁrst sample was taken 
before starting chemotherapy, the second sample was taken 
before radiation therapy and the third sample was taken after 
radiotherapy. All patients received the same drug regimen, 
including Taxotere (docetaxel), Adriamycin (doxorubicin) and 
cyclophosphamide in chemotherapy. Concerning radiother­
apy, all patients received radiation dose of 54 Gy in the chest 
wall and supraclavicular regions as a standard protocol deliv­
ered by the Phoenix radiotherapy machine. This study was 
approved by the ethical committee of Golestan University of 
medical sciences and patients participated on a voluntary and 
conscious basis. 
2.1. Statistical test 
Statistical analysis was performed using the SPSS software 
(v.16.0). Mean values and standard deviations were calculated 
for all parameters. Pearson’s correlation was used to correlate 
the markers of oxidative injury (MDA levels and OF). Com­
parisons between each stage of treatment were done using 
a t-test. 
3. Results 
The mean and standard deviation age of the patients 
was 51.5± 1.05 years and the average radiation dose was 
4693± 219.4 cGy. Plasma level of MDA and erythrocyte OF 
increased during three stages (Table 1), but no signiﬁcant sta­
tistical difference was observed (Table 2). 
Despite of the increasing trend of MDA and OF in each stage 
compared to the previous stage, no signiﬁcant difference was 
found between groups (P > 0.05). 
4. Discussion 
This study evaluated the levels of MDA and OF in patients with 
breast cancer who had undergone chemotherapy and radio­
therapy. The comparison of the mean of MDA levels and OF 
showed an increasing trend from beginning to end of treat­
ment. 
Few studies have been performed on this subject. Some 
results are in accordance with ours, while some others are herapy and chemotherapy on osmotic fragility of red blood cells and
t Oncol Radiother (2014), http://dx.doi.org/10.1016/j.rpor.2014.11.002
          
    
       
         
       
      
         
        
and colleagues evaluated the effects of gamma radiother­
apy on the lipid peroxidation and osmotic fragility of rat 
erythrocytes. The authors found that MDA levels increased 
and rat erythrocyte fragility decreased after radiotherapy.12 In 
another study performed by Selim and coworkers to assess the 
effect of radiotherapy on the biophysical characteristics of the 
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Table 1 Mean, standard deviation, minimum and maximum levels of plasma malondialdehyde (MDA) and osmotic 
fragility (OF) during three phases of treatment. 
MDA1 (ng/ml) MDA2 (ng/ml) MDA3 (ng/ml) OF1 (g/dl) OF2 (g/dl) OF3 (g/dl) 
Mean 1.48 1.60 1.88 0.52 0.54 0.56 
SD 0.95 1.18 1.26 0.035 0.028 0.022 
Minimum 0.50 0.30 0.60 0.50 0.50 0.55 
Maximum 4.00 4.80 3.90 0.60 0.60 0.60 
Table 2 Comparison of mean levels of malondialdehyde between stages of treatment. 
MDA (ng/ml) P value OF (g/dl) P value 
.897 
.190 
.902 
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SD±mean 
C1-C2
C2-C3
C1-C3
−0.05 ± 1.52 
−0.75 ± 1.45 
−0.085 ± 1.77 
0
0
0
C1: before chemotherapy; C2: before radiotherapy; C3: after radiother
rythrocyte membrane, such as the fragility of red blood cells
n rats, the results showed that the average osmotic fragility
as decreased.13 These two studies were inconsistent with
he present study. The results showed, despite plasma MDA
nd OF increasing levels during treatment stages, that there
as no signiﬁcant difference between them. 
Studies show that increasing the MDA levels from radio­
therapy can constitute cross connections with the ﬁrst amino
group of proteins or membrane phospholipids, leading to
more strength of erythrocyte membranes. This event could
possibly cause resistance of the erythrocyte membrane to
hemolysis in creating hypotonic conditions to measure OF.12 
his event might represent no changes in the OF level dur­
ng the treatment stages in this study. Although for a more
ccurate conclusion further studies with a larger statisti­
al population are needed. Dolan and coworkers assumed
hat aerobic exercise training increases RBC production. The
esults showed that the regular exercise did not have a pro­
ective effect against the decline in Hb in patients with
reast cancer who were under chemotherapy, but there was a
tronger association between Hb and VO2 peak.7 
Knopik-Skrock and coworkers evaluated the hemoly­
is process caused by amphotericin-Bin erythrocytes in
omen with breast cancer, before and during treatment
(surgery, chemotherapy). A signiﬁcant increase in resistance
to amphotericin-B was observed after surgery (P < 0.01) that
was appropriate with the decrease in the erythrocyte number,
hemoglobin and hematocrit. Chemotherapy did not change
the resistance of erythrocytes to amphotericin-B. Osmotic
fragility of patient erythrocytes did not show any signiﬁcant
ifferences compared with healthy subjects. This indicates
that the resistance of erythrocytes to amphotericin-B was 
ot determined by the membrane’s volume and surface
rea,14 which is compatible with the present study. Cetin
nd colleagues assayed plasma antioxidant concentration in
patients treated with high dose chemotherapy. They mea­Please cite this article in press as: Khoshbin AR, et al. The effect of radioth
plasma levels of malondialdehyde in patients with breast cancer. Rep Prac
              
          
       
      
       
         
         
           
         
sured zinc, silver, iron in erythrocytes, MDA, superoxide 
dismutase (SOD) and glutathione peroxidase (GSH-Px) before 
high dose chemotherapy (baseline), before stem cell trans­
plantation (day 1) and after stem cell transplantation (days 1, 
3 and 6). After high dose chemotherapy, a signiﬁcant increase 
was observed in the levels of MDA, GSH-Px and SOD. On the 
other hand, Copper levels remained the same, while the levels   
   
   
   
         
        
           
        
   
        
      
        
         
      
    
        
        
         
       
          
         
          
       
       
          
       
       
 
 
           
        
        
          
         
       
         
SD ± mean 
−0.025 ± 0.05 
−0.011 ± 0.033 
−0.025 ± 0.057 
0.072 
0.347 
0.227 
of iron and zinc in erythrocytes were increased. A signiﬁ­
cant correlation was observed between the levels of MDA,
GSH-Px and SOD (P < 0.05). The results showed that high dose
chemotherapy causes an increase in the oxidative stress and
the reactive oxygen species.15 
Ladas and coworkers considered the fact that many can­
cer patients take antioxidant nutritional supplements to
improve long-term outcomes, but still the efﬁcacy and safety
of antioxidants are not known. Their study suggested that the
talantioxidant status (measured by total radical antioxidant
parameters) decreases during cancer treatment.16 
Volker and coworkers evaluated the safety and efﬁcacy of
EpoetinAlfa in a second randomization of the intense dose-
dense arm of the 1284 patients. The primary efﬁcacy end
points consisting change in hemoglobin level from baseline
to cycle 9 and the percentage of people needed blood transfu­
sion. The results showed that EpoetinAlfa did not decrease in
emoglobin level versus the control group (P < 0.01) and sta­
istically signiﬁcant reduction of the percentage of patients
equiring blood transfusion. However, the incidence of throm­
otic events increased (7% vs. 3% in the control group). After
2-month treatment follow-up with EpoetinAlfa, no effect was 
bserved on overall survival, relapse-free survival, or intra-
ammary relapse.17 
5. Conclusion 
The levels of MDA and OF at each stage of the treat­
ment showed no signiﬁcant difference, but its average level
increased during the three stages of treatment. The osmotic
fragility rate did not show changes in any of the three
stages. According to how much the level of lipid peroxidation
increases in cancer, radiotherapy can increase it furthermore.
Assay of OF in patients with long duration radiotherapy orerapy and chemotherapy on osmotic fragility of red blood cells and
t Oncol Radiother (2014), http://dx.doi.org/10.1016/j.rpor.2014.11.002
          
    
  
  
 
chemotherapy was recommended. 
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